Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
NEJM 330:613-622, Lipton,S.A.&Rosenberg,P.A., 1994
A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
NEJM 330:585-591, Bensimon,G.,et al, 1994
Pharmacotherapy of Aphasia:A Critical Review
Stroke 25:1282-1289, Small,S.L., 1994
Chronic Daily Headache
Neurol 42:32-36, Sheftell,F.D., 1992
Tourette Syndrome and Other Tic Disorders, Diagnosis, Pathophysiology, and Treatment
Medicine 70:15-32, Singer,H.S.&Walkup,J.T., 1991
The Bioloigcal Basis for the Treatment of Acute Stroke
Neurol 41:1867-1873, Scheinberg,P., 1991
Age-Associated Memory Impairment:A Role for Catecholamines
Neurol 40:526-530, McEntee,W.J.&Crook,T.H., 1990
Restorative Neurology, Drugs and Recovery Following Stroke
Stroke 21:1636-1640, Goldstein,L.B.&Davis,J.N., 1990
Drugs Acting on 5-Hydroxytryptamine Receptors
Editorial, Lancet 2:717-7191989., , 1989
Alzheimer's Disease
NEJM 314:964-973, Katzman,R., 1986
Neural Transplantation:Scientific Gains & Clinical Perspectives
Neurol 36:389-392, Fishman,P.S., 1986
Neurotransmitters & CNS Disease, The Future
Lancet 2:1381-1385, Bloom,F.E., 1982